Journal of Parkinson s Disease · 2015 · 13 citations · 53 references
MedicineNeurosciencePharmacologyNeurochemistryNeuropharmacologyPharmacodynamicsDopaminergic PharmacologyNeurochemical PharmacologyNeurodegenerative Disease PharmacologyParkinson DiseaseRodent PhysiologyRodent ToxicologyAcute Neurotoxic EffectsBody Core TemperatureBody TemperatureBrain Temperature RegulationCore Body TemperatureHypothermiaInduced HypothermiaRodent Neuropharmacology
BACKGROUND: MPTP and paraquat are two compounds that have been used to model Parkinson's disease in mice. Previous studies in two non-traditional strains of mice have shown that a single dose of MPTP can induce changes in body temperature, while the effects of paraquat have not been examined. Examination of body temperature is important since small fluctuations in an animal's core temperature can significantly affect drug metabolism, and if significant enough can even culminate in an animal's death. OBJECTIVE: To determine how external heating can alter the survival of C57BL/6J mice following MPTP administration. METHODS: In this study, we examine the effects of MPTP (4×20 mg/kg, 2 hours apart) and paraquat (2×10 mg/kg/week for 3 weeks) on core temperature of C57BL/6J mice. Correlations of purine and catecholamine levels were also done in mice treated with MPTP. RESULTS: We find that MPTP induces a significant hypothermia in C57BL/6J mice that reduces their core temperature below the limit of fatal hypothermia. Unlike MPTP, paraquat did not induce a significant hypothermia. Placement of animals on heating pads significantly abrogates the loss of core temperature. In both heated and non-heated conditions, mice treated with MPTP showed a significant depletion of ATP within 2 hours of administration in both striatum and SN that started to recover 2 hours after MPTP administration was complete. Striatal DA and DOPAC are significantly reduced starting 4-6 hours after MPTP. CONCLUSIONS: The fatal hypothermic effects of MPTP can be abrogated through use of external heating.
53
Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
J. William Langston, Philip L. Ballard, James W. Tetrud et al. · Science · 1983 · 4.9K citations
Rotenone, Paraquat, and Parkinson’s Disease
Caroline M. Tanner, Freya Kamel, G. Webster Ross et al. · Environmental Health Perspectives · 2011 · 1.5K citations · Full text
Medicine, Neurology, Toxicology +17
Protocol for the MPTP mouse model of Parkinson's disease
Vernice Jackson‐Lewis, Serge Przedborski · Nature Protocols · 2007 · 1.1K citations